OpenBilldrug price receipt

NADAC week of 2026-10-14

BUMETANIDE 0.5 MG TABLET

For 30 tablets

Pharmacies pay

$3.86 filed

30 × $0.12883 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$13.03 filed

30 × $0.43436 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.4× estimated

Medicare paid 3.4× what pharmacies pay.

Part D averages every strength and form sold under “Bumetanide*” / “Bumetanide” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$9.44 estimated

$3.86 + $0.58 (15%) + $5.00 fee per fill = $9.44

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

BUMETANIDE 0.5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as bumetanide.

FDA gives its dosage form as tablet and its route as oral.

FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Sandoz Inc, Rising Pharma Holdings, Inc and Edenbridge Pharmaceuticals LLC.

FDA’s Established Pharmacologic Class for it is Loop Diuretic.

The NADAC file of 2026-10-14 prices it under 15 NDCs (National Drug Codes); the FDA directory lists 12 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $3.86 for 30 tablets (30 × $0.12883 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The 11 labelers

LabelerNDCsPharmacies pay per unit
Sandoz Inc2$0.12883 per EA filed
Advagen Pharma Limited1$0.12883 per EA filed
Amneal Pharmaceuticals NY LLC1$0.12883 per EA filed
AvPAK1$0.12883 per EA filed
Edenbridge Pharmaceuticals LLC.1$0.12883 per EA filed
Exelan Pharmaceuticals, Inc.1$0.12883 per EA filed
Lifestar Pharma LLC1$0.12883 per EA filed
NorthStar Rx LLC1$0.12883 per EA filed
Rising Pharma Holdings, Inc1$0.12883 per EA filed
Solco Healthcare LLC1$0.12883 per EA filed
Sun Pharmaceutical Industries, Inc.1$0.12883 per EA filed
Not listed as a package in the FDA directory3$0.12883 per EA filed
All 15 NDCs, with labeler and price
  • 00185-0128-01 · Sandoz Inc · $0.12883 per EA · eff. 2026-09-23 filed
  • 00185-0128-05 · Sandoz Inc · $0.12883 per EA · eff. 2026-09-23 filed
  • 14539-0700-01 · not listed as a package in the FDA directory · $0.12883 per EA · eff. 2026-09-23 filed
  • 14539-0700-05 · not listed as a package in the FDA directory · $0.12883 per EA · eff. 2026-09-23 filed
  • 16571-0679-01 · Rising Pharma Holdings, Inc · $0.12883 per EA · eff. 2026-09-23 filed
  • 42799-0119-01 · Edenbridge Pharmaceuticals LLC. · $0.12883 per EA · eff. 2026-09-23 filed
  • 43547-0896-10 · Solco Healthcare LLC · $0.12883 per EA · eff. 2026-09-23 filed
  • 50268-0130-11 · not listed as a package in the FDA directory · $0.12883 per EA · eff. 2026-09-23 filed
  • 50268-0130-15 · AvPAK · $0.12883 per EA · eff. 2026-09-23 filed
  • 51672-4223-01 · Sun Pharmaceutical Industries, Inc. · $0.12883 per EA · eff. 2026-09-23 filed
  • 69238-1489-01 · Amneal Pharmaceuticals NY LLC · $0.12883 per EA · eff. 2026-09-23 filed
  • 70756-0079-11 · Lifestar Pharma LLC · $0.12883 per EA · eff. 2026-09-23 filed
  • 72603-0889-01 · NorthStar Rx LLC · $0.12883 per EA · eff. 2026-09-23 filed
  • 72888-0019-01 · Advagen Pharma Limited · $0.12883 per EA · eff. 2026-09-23 filed
  • 76282-0797-01 · Exelan Pharmaceuticals, Inc. · $0.12883 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name bumetanide with BUMETANIDE 0.5 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
BUMETANIDE 0.5 MG TABLET this page
generic · tablet
$0.12883 per EA filed
eff. 2026-09-23
$0.43436 per EA filed
Part D 2024 average
BUMETANIDE 1 MG TABLET
generic · tablet
$0.10789 per EA filed
eff. 2026-09-23
$0.43436 per EA filed
Part D 2024 average
BUMETANIDE 2 MG TABLET
generic · tablet
$0.1819 per EA filed
eff. 2026-09-23
$0.43436 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 15 NDCs’ NADAC prices is $0.12883 per EA filed.

Of the 12 other products in FDA’s Loop Diuretic class priced per EA, 5 have a higher middle NADAC price and 7 a lower one. The one in the middle is TORSEMIDE 10 MG TABLET, at $0.06594 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $13.03 for 30 tablets, at an average of $0.43436 per EA in 2024 (2024-01-01 to 2024-12-31) for “Bumetanide*” and “Bumetanide”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 2,403,773 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

13 of the product’s 15 NDCs have this Medicare figure; the other 2 do not, and the interactive card says why for each.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for BUMETANIDE 0.5 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Bumetanide* / Bumetanide: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. Only NADAC NDCs whose FDA route includes ORAL point at this name (61 of the 67 the name join matched); NDCs of another route or with no known FDA route do not. 5 of the 61 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code).